摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-乙炔基-3-苯基苯 | 58650-11-6

中文名称
1-乙炔基-3-苯基苯
中文别名
3-乙炔基-1,1'-联苯
英文名称
3-ethynylbiphenyl
英文别名
3-ethynyl-1,1′-biphenyl;3-ethynyl-1,1'-biphenyl;3-Biphenylylacetylene;1-ethynyl-3-phenylbenzene
1-乙炔基-3-苯基苯化学式
CAS
58650-11-6
化学式
C14H10
mdl
——
分子量
178.233
InChiKey
PIARMLHJPVJQKG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    311.0±21.0 °C(Predicted)
  • 密度:
    1.06±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.8
  • 重原子数:
    14
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    0
  • 氢给体数:
    0
  • 氢受体数:
    0

安全信息

  • 危险性防范说明:
    P264,P280,P302+P352,P337+P313,P305+P351+P338,P362+P364,P332+P313
  • 危险性描述:
    H315,H319

SDS

SDS:420c23590f3d2e25061ec1194896697a
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-乙炔基-3-苯基苯 在 palladium diacetate 、 一氯化碘三(2,6-二甲氧基苯基)磷 作用下, 以 二氯甲烷 为溶剂, 生成 6-(biphenyl-3-yl)-5-iodo-4-methyl-2H-pyran-2-one
    参考文献:
    名称:
    Discovery of a novel series of N -hydroxypyridone derivatives protecting astrocytes against hydrogen peroxide-induced toxicity via improved mitochondrial functionality
    摘要:
    Astrocytes play a key role in brain homeostasis, protecting neurons against neurotoxic stimuli such as oxidative stress. Therefore, the neuroprotective therapeutics that enhance astrocytic functionality has been regarded as a promising strategy to reduce brain damage. We previously reported that ciclopirox, a well-known antifungal N-hydroxypyridone compound, protects astrocytes from oxidative stress by enhancing mitochondrial function. Using the N-hydroxypyridone scaffold, we have synthesized a series of cytoprotective derivatives. Mitochondrial activity assay showed that N-hydroxypyridone derivatives with biphenyl group have comparable to better protective effects than ciclopirox in astrocytes exposed to H2O2. N-hydroxypyridone derivatives, especially 11g, inhibited membrane-induced deterioration of mitochondrial membrane potential and oxygen consumption rate, and significantly improved cell viability of astrocytes. The results indicate that the N-hydroxypyridone motif can provide a novel cytoprotective scaffold for astrocytes via enhancing mitochondrial functionality. (C) 2017 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2016.12.052
  • 作为产物:
    描述:
    溴苯三苯基膦氯金magnesium 作用下, 以 四氢呋喃乙腈 为溶剂, 反应 33.08h, 生成 1-乙炔基-3-苯基苯
    参考文献:
    名称:
    金(i)催化的芳基重氮盐与有机锡的交叉偶联反应†
    摘要:
    描述了金(I)催化的芳基重氮盐与有机锡烷的交叉偶联反应。这种氧化还原中性策略为各种联芳基,乙烯基芳烃和芳基乙炔提供了一种有效的方法。用NMR和ESI-MS监测反应为原位形成Ph 3 PAu I R(R =芳基,乙烯基和炔基)物种提供了有力证据,这对于激活芳基重氮盐至关重要。
    DOI:
    10.1039/c8ob00630j
点击查看最新优质反应信息

文献信息

  • Iron-Catalyzed Vinylzincation of Terminal Alkynes
    作者:Qiang Huang、Yu-Xuan Su、Wei Sun、Meng-Yang Hu、Wei-Na Wang、Shou-Fei Zhu
    DOI:10.1021/jacs.1c11072
    日期:2022.1.12
    Organozinc reagents are among the most commonly used organometallic reagents in modern synthetic chemistry, and multifunctionalized organozinc reagents can be synthesized from structurally simple, readily available ones by means of alkyne carbozincation. However, this method suffers from poor tolerance for terminal alkynes, and transformation of the newly introduced organic groups is difficult, which
    有机锌试剂是现代合成化学中最常用的有机金属试剂之一,多官能化的有机锌试剂可以通过炔烃碳酰化从结构简单、容易获得的有机锌试剂中合成。但该方法对末端炔烃的耐受性较差,且新引入的有机基团难以转化,限制了其应用。在此,我们报告了一种由新开发的带有 1,10-菲咯啉-亚胺配体的铁催化剂催化的末端炔烃的乙烯基锌化方法。该方法提供了从现成的乙烯基锌试剂和末端炔烃中有效获取具有多种结构和官能团的新型有机锌试剂的途径。该方法具有优异的官能团耐受性(可耐受的官能团包括氨基、酰胺、氰基、酯、羟基、磺酰基、缩醛、膦酰基、吡啶基),良好的底物范围(合适的末端炔烃包括具有各种官能团的芳基、烯基和烷基乙炔)组),以及高化学选择性、区域选择性和立体选择性。该方法可以显着提高包括维生素A在内的各种重要生物活性分子的合成效率。机理研究表明,本研究开发的新型铁-1,10-菲咯啉-亚胺催化剂具有极其拥挤的反应袋,促进了化合物的高
  • 1-CYANO-PYRROLIDINE DERIVATIVES AS DUB INHIBITORS
    申请人:MISSION THERAPEUTICS LIMITED
    公开号:US20200331888A1
    公开(公告)日:2020-10-22
    The present invention relates to novel compounds and methods for the manufacture of inhibitors of deubiquitylating enzymes (DUBs). In particular, the invention relates to the inhibition of ubiquitin C-terminal hydrolase 30 or ubiquitin specific peptidase 30 (USP30). The novel compounds have formula (I): (Formula (I)) or are pharmaceutically acceptable salts thereof, wherein: R 1a , R 1b , R 1c , R 1d , R 1e and R 1f each independently represent hydrogen, optionally substituted C 1 -C 6 alkyl or optionally substituted C 3 -C 4 cycloalkyl, or R 1b and R 1c together form an optionally substituted C 3 -C 6 cycloalkyl ring, or R 1d and R 1e together form an optionally substituted C 3 -C 6 cycloalkyl ring; R 2 represents hydrogen or optionally substituted C 1 -C 6 alkyl; A represents an optionally further substituted 5 to 10 membered monocyclic or bicyclic heteroaryl, heterocyclyl or aryl ring; L represents a covalent bond or linker; B represents an optionally substituted 3 to 10 membered monocyclic or bicyclic heterocyclyl, heteroaryl, cycloalkyl or aryl ring; and when -A-L-B is at position x attachment to A is via a carbon ring atom of A, and either: A cannot be triazolopyridazinyl, triazolopyridinyl, imidazotriazinyl, imidazopyrazinyl or pyrrolopyrimidinyl; or B cannot be substituted with phenoxyl; or B cannot be cyclopentyl when L is an oxygen atom.
    本发明涉及新化合物和制备去泛素化酶(DUBs)抑制剂的方法。具体而言,本发明涉及抑制泛素C-末端水解酶30或泛素特异性肽酶30(USP30)。这些新化合物的化学式为(I):(化学式(I)),或其药学上可接受的盐,其中:R1a,R1b,R1c,R1d,R1e和R1f分别独立地代表氢,可选择地取代的C1-C6烷基或可选择地取代的C3-C4环烷基,或者R1b和R1c共同形成一个可选择地取代的C3-C6环烷基环,或者R1d和R1e共同形成一个可选择地取代的C3-C6环烷基环;R2代表氢或可选择地取代的C1-C6烷基;A代表一个可选择地进一步取代的5到10个成员的单环或双环杂环芳基,杂环烷基或芳基环;L代表一个共价键或连接物;B代表一个可选择地取代的3到10个成员的单环或双环杂环烷基,杂环芳基,环烷基或芳基环;当-A-L-B位于位置x时,通过A的一个碳环原子连接到A,且:A不能是三唑吡啶基,三唑吡啉基,咪唑三嗪基,咪唑吡嗪基或吡咯嘧啶基;或者B不能被苯氧基取代;或者当L是氧原子时,B不能是环戊基。
  • Progress towards water-soluble triazole-based selective MMP-2 inhibitors
    作者:Benjamin Fabre、Kamila Filipiak、José María Zapico、Natalia Díaz、Rodrigo J. Carbajo、Anne K. Schott、María Paz Martínez-Alcázar、Dimas Suárez、Antonio Pineda-Lucena、Ana Ramos、Beatriz de Pascual-Teresa
    DOI:10.1039/c3ob41046c
    日期:——
    Water solubility is a key aspect that needs to be addressed to obtain drug-like compounds. In an effort to improve the water solubility of our recently reported nanomolar matrix metalloproteinase type 2 (MMP-2) inhibitors based on triazole-substituted hydroxamates, we synthesized a new series of α-sulfone, α-tetrahydropyran and α-piperidine, α-sulfone clicked hydroxamates and determined their inhibitory activities against both MMP-2 and MMP-9. The best results were found for 13e, a water-soluble compound that displays a low nanomolar activity against MMP-2 and is 26-fold less active against MMP-9. This finding allowed us to pursue in vitro permeability through the Caco-2 monolayer and opened the possibility of carrying out further preclinical investigations. Docking and MD simulations have been performed in order to rationalize the biological results. The inhibitory activity of this compound against a panel of ten MMPs was determined showing an interesting MMP-2/MMP-1, -8, and -14 selectivity profile. The cytotoxicity and anti-invasive activity of the compounds on highly metastatic human fibrosarcoma tumor cells (HT1080) were determined, showing, at 10 μM concentration, a decrease in cell invasiveness up to 80%.
    水溶性是获得类药物化合物需要解决的关键问题。为了提高我们近期报道的基于三唑取代的羟肟酸的纳摩尔级基质金属蛋白酶2型(MMP-2)抑制剂的水溶性,我们合成了一系列新的α-砜、α-四氢吡喃和α-哌啶、α-砜点击羟肟酸化合物,并测定了它们对MMP-2和MMP-9的抑制活性。最佳结果显示,化合物13e具有水溶性,对MMP-2表现出低纳摩尔活性,对MMP-9的活性降低了26倍。这一发现使我们能够进行Caco-2单层细胞的体外通透性研究,并开启了进一步临床前研究的可能性。为了合理化生物学结果,我们进行了对接和分子动力学(MD)模拟。测定了该化合物对十个MMP组分的抑制活性,显示了有趣的MMP-2/MMP-1、-8和-14选择性谱。测定了这些化合物对高转移性人纤维肉瘤肿瘤细胞(HT1080)的细胞毒性和抗侵袭活性,结果显示,在10 μM浓度下,细胞侵袭性降低了高达80%。
  • Visible‐Light‐Induced [4+2] Annulation of Thiophenes and Alkynes to Construct Benzene Rings
    作者:Chunlan Song、Xin Dong、Zhongjie Wang、Kun Liu、Chien‐Wei Chiang、Aiwen Lei
    DOI:10.1002/anie.201905971
    日期:2019.8.26
    The [4+2] annulation represents an elegant and versatile synthetic protocol for the construction of benzene rings. Herein, a strategy for visible-light induced [4+2] annulation of thiophenes and alkynes, to afford benzene rings, is presented. Under simple and mild reaction conditions, the ready availability and structural diversity of thiophenes and alkynes permit the facile synthesis of several substituted
    [4 + 2]环空表示用于苯环构建的优雅且通用的合成方案。在本文中,提出了一种策略,用于可见光诱导的噻吩和炔烃的[4 + 2]环化,以提供苯环。在简单温和的反应条件下,噻吩和炔烃的易得性和结构多样性允许轻松合成数个取代的芳环。有价值的药物和氨基酸也被很好地耐受。此外,DFT计算解释了该反应的高区域选择性。
  • Synthesis and structure–activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap group
    作者:Po C. Chen、Vishal Patil、William Guerrant、Patience Green、Adegboyega K. Oyelere
    DOI:10.1016/j.bmc.2008.03.050
    日期:2008.5
    suberoylanilide hydroxamic acid-like (SAHA-like) HDAC inhibitors. Using "click" chemistry (Huisgen cycloaddition reaction), several triazole-linked SAHA-like hydroxamates were synthesized. Structure-activity relationship revealed that the position of the triazole moiety as well as the identity of the cap group markedly affected the in vitro HDAC inhibition and cell growth inhibitory activities of this
    组蛋白脱乙酰基酶(HDAC)抑制是一种最近经过临床验证的癌症治疗策略。迄今为止,鉴定出的小分子HDAC抑制剂可分为三个不同的结构基序:锌结合基团(ZBG),疏水性接头和识别帽基团。在这里,我们报告了1,2,3-三唑环作为表面识别帽基团连接部分的适宜性,该表面识别基团为亚磺酰苯胺异羟肟酸样(SAHA样)HDAC抑制剂。使用“点击”化学(Huisgen环加成反应),合成了几种三唑连接的SAHA样异羟肟酸酯。结构-活性关系表明,三唑部分的位置以及帽基的身份显着影响此类化合物的体外HDAC抑制和细胞生长抑制活性。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐